| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/26/1994 | EP0272304B1 A process for producing a coagulation active complex of factor viii fragments |
| 01/25/1994 | US5281716 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds |
| 01/25/1994 | US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI |
| 01/25/1994 | US5281626 Benzenesulfonamide derivatives |
| 01/25/1994 | US5281585 Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets |
| 01/23/1994 | CA2100429A1 1n substituted pyrazino [2,3-c]-1,2,6,-thiadiazine 2,2- dioxides and process for the preparation thereof |
| 01/22/1994 | CA2100944A1 3-(hydroxybenzylidenyl)-indoline-2-ones, their preparation and the pharmaceutical compositions containing them |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001461A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 01/20/1994 | WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
| 01/20/1994 | WO1994001123A1 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder |
| 01/20/1994 | WO1994001120A1 Purification of factor ix |
| 01/20/1994 | CA2139945A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor xa |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
| 01/19/1994 | EP0579277A1 Imidazole derivatives, their preparation and their use as synthetic intermediates |
| 01/19/1994 | EP0578728A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa |
| 01/19/1994 | CN1080917A Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/18/1994 | US5280017 Use of dextrin derivatives for the treatment of acidic conditions |
| 01/18/1994 | US5279812 Radiolabeled anticoagulant peptides |
| 01/18/1994 | CA1326326C Platelet-aggregation inhibitors |
| 01/18/1994 | CA1326216C Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins |
| 01/16/1994 | CA2100626A1 4-aminoquinazoline derivatives |
| 01/12/1994 | EP0578535A1 New peptide derivates active in the process of cell adhesion, a method to prepare them end pharmaceutical compositions containing them |
| 01/12/1994 | EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor |
| 01/12/1994 | EP0578083A2 Cyclic adhesion inhibitors |
| 01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/12/1994 | EP0577785A1 Fluorinated compounds as oxygen transport agents |
| 01/12/1994 | EP0577775A1 Anti-thrombotic peptides and pseudopeptides |
| 01/12/1994 | EP0577699A1 Compositions and methods to inhibit the activation of active factor xiii |
| 01/12/1994 | CN1080658A 蛋白质c衍生物 C protein derivative |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278144 Antithrombosis agents |
| 01/11/1994 | CA1326107C Heterocyclic ketones |
| 01/11/1994 | CA1326030C Cyclohept[b]indolealkanoic acids |
| 01/11/1994 | CA1326022C 6-oxoprostaglandin-e derivatives, method for their manufacture and their use as pharmaceuticals |
| 01/06/1994 | WO1994000566A1 A thrombin blood fraction for use in a medical procedure |
| 01/06/1994 | WO1994000447A1 Novel cyclic lipid derivatives as potent paf antagonists |
| 01/06/1994 | WO1994000161A1 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids |
| 01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/05/1994 | EP0577151A1 Use of GHL-Cu as antiinflammatory agent |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576617A1 Composition and method containing optically pure (s) metoprolol. |
| 01/05/1994 | EP0576612A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 01/05/1994 | EP0396733B1 Improved extraction methods for preparing thromboplastin reagents |
| 01/05/1994 | CN1023409C Production method of nutritive liquid |
| 01/04/1994 | US5276049 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and methods of using the same |
| 01/04/1994 | US5276015 Lipoprotein associated coagulation inhibitor or tissue factor pathway inhibitor |
| 01/04/1994 | US5275946 Thrombolytic agents with modified kringle domains |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 12/31/1993 | CA2099698A1 Peptide derivatives involved in cellular adhesion processes, process for their preparation and pharmaceutical compositions comprising thereof |
| 12/29/1993 | EP0576049A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575557A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
| 12/29/1993 | EP0454739B1 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 12/29/1993 | EP0433275B1 Composition based on heparin micropolysaccharides, active when administered orally |
| 12/29/1993 | EP0365597B1 Improved processes for the treatment of vascular disease |
| 12/28/1993 | US5274098 Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them |
| 12/28/1993 | CA1325631C Phenothiazine derivatives with analgesic properties |
| 12/23/1993 | WO1993025205A1 Pyrazolopyridine compounds for the treatment of anemia |
| 12/23/1993 | WO1993025071A1 Production of human hemoglobin in transgenic pigs |
| 12/23/1993 | CA2137911A1 Production of human hemoglobin in transgenic pigs |
| 12/23/1993 | CA2112360A1 Bicyclic fibrinogen antagonists |
| 12/22/1993 | EP0575069A1 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of antithrombotic and anti-vasospastic compounds |
| 12/22/1993 | EP0575054A2 Protein C derivatives |
| 12/22/1993 | EP0574955A1 Production and use of IL-6 |
| 12/22/1993 | EP0574808A1 Amidine-biphenyl derivatives, process for their production & medical preparation containing them |
| 12/22/1993 | EP0574774A1 Substituted benzothiazolyl- and quinoxalyl methoxy-phenyl acetic acid derivatives |
| 12/22/1993 | EP0574510A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 12/22/1993 | EP0574494A1 Indoles useful as platelet activating factor antagonists |
| 12/22/1993 | EP0383777B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 12/22/1993 | CN1023219C Substituted imidazole derivatives and their preparation and use |
| 12/21/1993 | US5272161 Indolesulphonamide-substituted dihydropyridines |
| 12/21/1993 | US5272158 Fibrinogen receptor antagonists |
| 12/21/1993 | US5272076 Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA |
| 12/19/1993 | CA2098535A1 Linear peptides |
| 12/19/1993 | CA2096667A1 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds |
| 12/18/1993 | CA2098366A1 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
| 12/15/1993 | EP0573848A2 Bile-acid derivatives, a process for their production and their use as medicines |
| 12/15/1993 | EP0573605A1 Preparation of factor ix |
| 12/15/1993 | EP0573545A1 Monoclonal antibodies against receptor-induced binding sites |
| 12/15/1993 | EP0573510A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 12/15/1993 | CN1079468A Sulfonamide endothelin antagonists |
| 12/14/1993 | US5270316 Condensed purine derivatives |
| 12/14/1993 | US5270178 Vectors and compounds for expression of zymogen forms of human protein C |
| 12/14/1993 | CA1325209C Certain 2-substituted adenosine derivatives |
| 12/14/1993 | CA1325205C Substituted flavanoid compounds, their salts, their manufacture and medicines containing these materials |
| 12/12/1993 | CA2098158A1 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/09/1993 | WO1993024635A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
| 12/09/1993 | WO1993024527A1 Peptide inhibitors of selectin binding |
| 12/09/1993 | WO1993024524A1 Single chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024523A1 Double chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024522A1 Double chain peptide compounds having hemoregulatory activity |
| 12/09/1993 | WO1993024520A1 Conformationally restrained peptide analogs as antiplatelet agents |